STAT+: The FDA questions underlying Utah\u2019s AI prescription pilot
\n \t
\n
<\/BR>
\n
\n \t
\n
<\/BR><\/p>\n
One of my favorite science communicators, Alex Dainis, is in the middle of a short-form video series where she\u2019s tasting every amino acid.\u00a0<\/p>\n
Each video is great, but her reaction to tasting cysteine<\/a> is memorable. I am obsessed; you should give a couple of the videos a watch.\u00a0<\/p>\n You\u2019re reading the web edition of STAT\u2019s AI Prognosis newsletter, our subscriber-exclusive guide to artificial intelligence in health care and medicine.\u00a0Sign up to get it<\/a>\u00a0delivered in your inbox every Wednesday.<\/em>\u00a0<\/p>\n If you\u2019re tuned into the health AI discussion online, you\u2019re probably sick of hearing takes on Utah\u2019s artificial intelligence pilot program, where Doctronic will\u00a0authorize prescription renewals with AI.\u00a0<\/p>\n It sounds great \u2014 a step toward letting AI do more things\u00a0in a \u201csandbox\u201d environment sanctioned by the state government. But what, exactly, is the legality of this program?\u00a0<\/p>\n Continue to STAT+ to read the full story\u2026<\/a><\/p>\n<\/div>\nAsk for forgiveness, not permission<\/h2>\n